Mir-17~92 cooperates with RB pathway mutations to promote retinoblastoma

Genes and Development

Volumn 25, Issue 16, 2011, Pages 1734-1745

  Conkrite, Karina ^a   Sundby, Maggie ^a   Mukai, Shizuo ^b   Michael Thomson, J ^c   Mu, David ^c   Hammond, Scott M ^d   MacPherson, David ^c  

^a GEOPHYSICAL LABORATORY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; MicroRNA; MiR 17; 92; Rb; Retina; Retinoblastoma

Indexed keywords

MICRORNA; MIR 17 92; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P107; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN METASTASIS; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DELETION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA CELL; RETINA DEVELOPMENT; RETINOBLASTOMA; UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICRORNAS; MULTIGENE FAMILY; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; PREGNANCY; RETINA; RETINOBLASTOMA; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; SIGNAL TRANSDUCTION;

MURINAE;

EID: 84860417150     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.17027411     Document Type: Article

References (43)

1. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
2. Burkhart DL, Sage J. 2008. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 8: 671-682.
3. Chen D, Livne-bar I, Vanderluit JL, Slack RS, Agochiya M, Bremner R. 2004. Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 5: 539-551.
4. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML, Berns A, Te Riele H. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359: 328-330.
5. Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, Kolle G, Gabrielli B, Grimmond SM. 2008. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol 9: R127. doi: 10.1186/gb-2008-9-8-r127.
6. Corson TW, Gallie BL. 2007. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer 46: 617-634.
7. Dyer MA, Bremner R. 2005. The search for the retinoblastoma cell of origin. Nat Rev Cancer 5: 91-101.
8. Hackenberg M, Sturm M, Langenberger D, Falcon-Perez JM, Aransay AM. 2009. MiRanalyzer: a microRNA detection and analysis tool for next-generation sequencing experiments. Nucleic Acids Res 37: W68-W76. doi: 10.1093/nar/gkp347.
9. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T. 2005. A polycistronic microRNA cluster, miR-17-92, is over-expressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632.
10. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, et al. 2005. A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
11. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, Kobayashi SV, Lim L, Burchard J, Jackson AL, et al. 2008. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 28: 2167-2174.
12. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295-300.
13. Johnson DA, Zhang J, Frase S, Wilson M, Rodriguez-Galindo C, Dyer MA. 2007. Neuronal differentiation and synaptogenesis in retinoblastoma. Cancer Res 67: 2701-2711.
14. Lakshmi B, Hall IM, Egan C, Alexander J, Leotta A, Healy J, Zender L, Spector MS, Xue W, Lowe SW, et al. 2006. Mouse genomic representational oligonucleotide microarray analysis: detection of copy number variations in normal and tumor specimens. Proc Natl Acad Sci 103: 11234-11239.
15. Lambertz I, Nittner D, Mestdagh P, Denecker G, Vandesompele J, Dyer MA, Marine JC. 2010. Monoallelic but not biallelicloss of Dicer1 promotes tumorigenesis in vivo. Cell Death Differ 17: 633-641.
16. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294.
17. Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E, Jacks T. 1996. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev 10: 1621-1632.
18. Lu Y, Thomson JM, Wong HY, Hammond SM, Hogan BL. 2007. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol 310: 442-453.
19. MacPherson D. 2008. Insights from mouse models into human retinoblastoma. Cell Div 3: 9. doi: 10.1186/1747-1028-3-9.
20. MacPherson D, Dyer MA. 2007. Retinoblastoma: from the two-hit hypothesis to targeted chemotherapy. Cancer Res 67: 7547-7550.
21. MacPherson D, Sage J, Crowley D, Trumpp A, Bronson RT, Jacks T. 2003. Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system. Mol Cell Biol 23: 1044-1053.
22. MacPherson D, Sage J, Kim T, Ho D, McLaughlin ME, Jacks T. 2004. Cell type-specific effects of Rb deletion in the murine retina. Genes Dev 18: 1681-1694.
23. MacPherson D, Conkrite K, Tam M, Mukai S, Mu D, Jacks T. 2007. Murine bilateral retinoblastoma exhibiting rapid-onset, metastatic progression and N-myc gene amplification. EMBO J 26: 784-794.
24. Marquardt T, Ashery-Padan R, Andrejewski N, Scardigli R, Guillemot F, Gruss P. 2001. Pax6 is required for the multi-potent state of retinal progenitor cells. Cell 105: 43-55.
25. Martins RA, Zindy F, Donovan S, Zhang J, Pounds S, Wey A, Knoepfler PS, Eisenman RN, Roussel MF, Dyer MA. 2008. N-myc coordinates retinal growth with eye size during mouse development. Genes Dev 22: 179-193.
26. Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, de Keersmaecker K, McJunkin K, Zuber J, James T, Khan AA, Leslie CS, et al. 2010. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lympho-blastic leukaemia. Nat Cell Biol 12: 372-379.
27. Mendell JT. 2008. MiRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222.
28. Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P, de Stanchina E, D'Andrea A, Sander C, Ventura A. 2009. Genetic dissection of the miR-17;92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 23: 2806-2811.
29. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, Li QJ, Lowe SW, Hannon GJ, He L. 2009. miR-19 is a key oncogenic component of mir-17-92. Genes Dev 23: 2839-2849.
30. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, Yoshida Y, Seto M. 2004. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64: 3087-3095.
31. Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, Hobbs RM, Sportoletti P, Varmeh S, Egia A, Fedele G, et al. 2010. Identification of the miR-106b;25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3: ra29. doi: 10.1126/scisignal.2000594.
32. DaRobanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC, nnenberg JH, Berns A, Te Riele H. 1998. P107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12: 1599-1609.
33. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T. 2003. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424: 223-228.
34. Sengupta S, Nie J, Wagner RJ, Yang C, Stewart R, Thomson JA. 2009. MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells. Stem Cells 27: 1524-1528.
35. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F, Ferbeyre G, Chartrand P. 2007. An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282: 2135-2143.
36. Thomson JM, Parker J, Perou CM, Hammond SM. 2004. A custom microarray platform for analysis of microRNA gene expression. Nat Methods 1: 47-53.
37. Trumpp A, Depew MJ, Rubenstein JL, Bishop JM, Martin GR. 1999. Cre-mediated gene inactivation demonstrates that FGF8 is required for cell survival and patterning of the first branchial arch. Genes Dev 13: 3136-3148.
38. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, et al. 2008. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132: 875-886.
39. Wang Q, Li YC, Wang J, Kong J, Qi Y, Quigg RJ, Li X. 2008. MiR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130. Proc Natl Acad Sci 105: 2889-2894.
40. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
41. Woods K, Thomson JM, Hammond SM. 2007. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 282: 2130-2134.
42. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, Henderson JM, Kutok JL, Rajewsky K. 2008. Lymphoprolifer-ative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9: 405-414.
43. Zhang J, Schweers B, Dyer MA. 2004. The first knockout mouse model of retinoblastoma. Cell Cycle 3: 952-959.